Intellectual Property
The MaineHealth Innovation Intellectual Property Portfolio represents inventions by MaineHealth care team members that will advance the delivery of healthcare for the benefit of the public.
If you're interested in learning more about available technology or intellectual property at MaineHealth, please contact Todd Keiller, Director of Intellectual Property and Technology Transfer at innovation_center@mainehealth.org.
MaineHealth Available Technologies
CTHRC1-Targeting Antibodies for Colorectal Cancer
CTHRC1 targeting antibodies offer a novel immunotherapy and diagnostic solution for colorectal cancer by precisely inhibiting a key immune checkpoint molecule involved in tumor progression.
Breast Biopsy Clips
A novel design that increases breast biopsy marker visibility that can be manufactured more cost-effectively, efficiently and aims to reduce the need for additional or alternative procedures for the patient and reduce the cost of the biopsy procedure.
Comfort Bra
The Comfort Bra is designed in separate segments, decreasing risk for the undergarment to be used as a ligature. The garment allows patients to maintain dignity and modesty, and enables staff to provide trauma-informed care.
Compliant, Temperature-Stable Balloon for Use in Percutaneous Ablation Procedures
This device allows for effective separation of the treatment zone from temperature-sensitive structures, broadening the patient population amendable to ablation.
Halter-Clip
This implantable clip can be inserted through the g-tube site at the time of removal without anesthesia and promptes closure and healing, offering a minimally invasive option for g-tube site closure in an office based procedure.
Methods, Compositions, and Kits for Producing Beige Adipocytes and Treating Metabolic Disorders
This is a method to generate a renewable and unlimited source patient-matched beige adipocytes from induced pluripotent stem cells (iPSCs) that could be used to increase energy expenditure for potential weight loss and reversal of type 2 diabetes. This provides an unlimited supply of patient matched cellular material for therapeutic use, and cells are also useful for large scale screening of compounds that could increased energy expenditure and weight loss.
Methods to Inhibit Fatty Acid Binding Proteins (FABPs) for Cancer Treatment
Targeting and inhibiting FABPs offers a novel therapeutic strategy to reduce tumor growth and improve cancer patient outcomes. This technology involves methods to inhibit fatty acid binding proteins (FABPs), key players in the tumor microenvironment, using antibodies, nucleic acids, or small molecules to alter cancer progression.
Neck Saver Laptop Holder
This prototype offers a portable workstation that removes ergonomic risk factors when using a laptop, allowing users to attach the laptop to a monitor inside the holder that can be adjusted to fit the user. This innovation offers improved clinician comfort when working with patients, allowing them to focus on providing care and preventing pain and injury risk from sustaining abnormal neck postures.
Pocket Nodules
This novel patient education tool supports improved patient understanding and visualization of the diagnosis to support provider-patient shared decision making in treatment planning.
SpotRx (Medicated Adhesive Stickers)
Many skin conditions include small areas which are difficulty to treat with conventional topicals. These small adhesive patches improve spot treatment and patient satisfaction.
Trocar for Correct Chest Tube Placement
The Trocar for Correct Chest Tube Placement is an angled surgical trocar, a medical tool that will allow medical professionals to access the body cavity of a patient. The goal of the system is to avoid placing chest tubes into the lung fissure or other unwanted locations."
MaineHealth Companies Formed
Acuity, LLC. Acuity Behavioral Health was founded by a consortium of the nation’s leading behavioral health organizations, and the company’s product, the BHAI, is a predictive decision-support solution created as a clinical response to the increasingly acute status of mental health patients in inpatient settings. The BHAI provides an accurate and consistent measurement of patient acuity in behavioral healthcare settings to assist nursing staff administrators in planning for next-day staffing and patient needs.
Current Status: Acuity has received approval for implementing at MaineHealth and will begin with training staff at Spring Harbor Hospital to begin utilizing the tool with eventual expansion to all inpatient behavioral health locations across MaineHealth (Southern Maine Health Care, PenBay, MidCoast and MMC). The tool is currently being utilized at PineRest in Michigan and Cone Health in North Carolina.
Team: Kelly Barton, President, Maine Behavioral Healthcare, Jason Rosenberg, CNO for Maine Behavioral Healthcare
CAPE, LLC. (Collapsible Aerosolized Particle Enclosure), Protects patients and providers exposed to infectious airborne particles
Team: Samir Haydar, MD, Emergency Physician, MMC; Kaitlyn Main, MD, Emergency Resident, MMC; Liz Hamilton, MD, Emergency Resident, MMC; Paul Fitzpatrick, Medical Device Entrepreneur; Paul Tyson, Thermoformed Plastics; David Eagleson, Baker, Co
Cryptomedix: CryptoMedix (CMX) is dedicated to the development of a platform of "first in class" therapeutic antibodies targeting unique cryptic collagen sites within the tumor-associated matrix. Their lead drug candidate, CMX-102, a humanized IgG that recognizes cryptic sites exposed in tumor-modified collagen. Team: Peter Brooks, PhD, Bernd Seizinger, MD, Ph.D., CEO and Co-founder of CryptoMedix, Inc., Hemanshu Shah, Ph.D., MBA, Chief Business Officer CryptoMedix, Inc.. Marcel Rozencweig, MD, Chief Medical Officer CryptoMedix, Inc.
Satya Dx: Satya Diagnostics are manufacturing a novel diagnostic kit to improve breast cancer detection in earlier stages of the disease. Their patented NOHA blood test provides >90% accuracy in assessing treatment response, offering fast and easy diagnosis for timelier treatment. There is hope this novel diagnostic test will improve patient outcomes while also lowering cost of care.
Team: Sue Miesfeldt, MD* (CMO), Srinidi (Sri) Mohan, PhD, Chair & Professor, Department of Pharmaceutical Sciences & Administration, School of Pharmacy (at UNE), CTO; Mac McCabe, CFO; Val Krazman, Chairman of the Board
Soft Robotics Angiography, LLC: Was formed to make robotic tools for endovascular work in the body and brain that are more effective, capable and safer than the current generation of non-robotic tools.
Team: Robert D Ecker, MD Vice President - Chief of Neurosciences CEO, Founder SRA, LLC, Professor Mohsen Shahinpoor, PhD, Founder, SRA, LLC, Dr. Jeffrey Florman, Founder, SRA, LLC, Tyrgve Olsen, Director, Resonetics
Teach Me Rx, Creator of Pocket Nodules, a visually engaging learning experience for improved understanding of lung nodules. It may also reduce anxiety and encourage lung health stewardship for patients.
Current Status: The patient education tool is being used in select clinics in the US, Europe, Asia, Africa, Canada and South America as well as at MaineHealth Pen Bay Medical Center ED for explaining incidental pulmonary modules.
Team: Theresa Roelke, Adult Nurse Practitioner, Maine Health Institute of Research Maine Medical Partners